David Larsen
Stock Analyst at BTIG
(2.07)
# 2,975
Out of 5,174 analysts
109
Total ratings
37.36%
Success rate
-5.2%
Average return
Main Sectors:
Stocks Rated by David Larsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BTSG BrightSpring Health Services | Reiterates: Buy | $55 | $43.31 | +26.99% | 7 | Mar 19, 2026 | |
| LFMD LifeMD | Reiterates: Buy | $10 | $3.88 | +157.73% | 5 | Mar 10, 2026 | |
| TOI The Oncology Institute | Reiterates: Buy | $7 | $3.13 | +123.64% | 2 | Mar 9, 2026 | |
| MDLN Medline | Reiterates: Buy | $55 | $42.03 | +30.86% | 2 | Mar 9, 2026 | |
| PGNY Progyny | Maintains: Buy | $35 → $30 | $18.05 | +66.20% | 5 | Mar 5, 2026 | |
| EVH Evolent Health | Maintains: Buy | $10 → $8 | $2.25 | +255.56% | 9 | Feb 25, 2026 | |
| HIMS Hims & Hers Health | Downgrades: Neutral | n/a | $21.34 | - | 4 | Feb 24, 2026 | |
| HQY HealthEquity | Maintains: Buy | $130 → $110 | $82.10 | +33.98% | 6 | Feb 17, 2026 | |
| CCSI Consensus Cloud Solutions | Maintains: Buy | $37 → $40 | $25.33 | +57.92% | 4 | Feb 17, 2026 | |
| DOCS Doximity | Maintains: Buy | $80 → $50 | $24.34 | +105.42% | 3 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $11 | $6.45 | +70.54% | 3 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $40 | $24.02 | +66.53% | 3 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $11.57 | - | 4 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Suspends: Neutral | n/a | $2.97 | - | 3 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Suspends: Neutral | n/a | $0.44 | - | 2 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $340 | $179.11 | +89.83% | 4 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $15 | $8.15 | +84.05% | 4 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $1.10 | - | 4 | Sep 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $290 → $260 | $166.09 | +56.54% | 2 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7 | $1.11 | +530.63% | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $7 | $0.64 | +987.29% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $34.46 | - | 7 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $21.03 | +66.43% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.42 | - | 3 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $5.76 | - | 1 | Jan 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $207.23 | - | 6 | Nov 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $170 → $160 | $881.94 | -81.86% | 2 | May 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $74.02 | - | 5 | Apr 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $72.80 | +16.76% | 3 | Feb 9, 2018 |
BrightSpring Health Services
Mar 19, 2026
Reiterates: Buy
Price Target: $55
Current: $43.31
Upside: +26.99%
LifeMD
Mar 10, 2026
Reiterates: Buy
Price Target: $10
Current: $3.88
Upside: +157.73%
The Oncology Institute
Mar 9, 2026
Reiterates: Buy
Price Target: $7
Current: $3.13
Upside: +123.64%
Medline
Mar 9, 2026
Reiterates: Buy
Price Target: $55
Current: $42.03
Upside: +30.86%
Progyny
Mar 5, 2026
Maintains: Buy
Price Target: $35 → $30
Current: $18.05
Upside: +66.20%
Evolent Health
Feb 25, 2026
Maintains: Buy
Price Target: $10 → $8
Current: $2.25
Upside: +255.56%
Hims & Hers Health
Feb 24, 2026
Downgrades: Neutral
Price Target: n/a
Current: $21.34
Upside: -
HealthEquity
Feb 17, 2026
Maintains: Buy
Price Target: $130 → $110
Current: $82.10
Upside: +33.98%
Consensus Cloud Solutions
Feb 17, 2026
Maintains: Buy
Price Target: $37 → $40
Current: $25.33
Upside: +57.92%
Doximity
Feb 6, 2026
Maintains: Buy
Price Target: $80 → $50
Current: $24.34
Upside: +105.42%
Feb 2, 2026
Maintains: Buy
Price Target: $10 → $11
Current: $6.45
Upside: +70.54%
Feb 2, 2026
Maintains: Buy
Price Target: $45 → $40
Current: $24.02
Upside: +66.53%
Dec 18, 2025
Downgrades: Neutral
Price Target: n/a
Current: $11.57
Upside: -
Dec 12, 2025
Suspends: Neutral
Price Target: n/a
Current: $2.97
Upside: -
Dec 12, 2025
Suspends: Neutral
Price Target: n/a
Current: $0.44
Upside: -
Nov 21, 2025
Reiterates: Buy
Price Target: $340
Current: $179.11
Upside: +89.83%
Sep 18, 2025
Maintains: Buy
Price Target: $10 → $15
Current: $8.15
Upside: +84.05%
Sep 5, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.10
Upside: -
Nov 1, 2024
Maintains: Buy
Price Target: $290 → $260
Current: $166.09
Upside: +56.54%
Sep 17, 2024
Initiates: Buy
Price Target: $7
Current: $1.11
Upside: +530.63%
May 9, 2024
Maintains: Buy
Price Target: $11 → $7
Current: $0.64
Upside: +987.29%
Nov 3, 2023
Downgrades: Neutral
Price Target: n/a
Current: $34.46
Upside: -
Apr 28, 2022
Initiates: Buy
Price Target: $35
Current: $21.03
Upside: +66.43%
Nov 22, 2021
Downgrades: Neutral
Price Target: n/a
Current: $5.42
Upside: -
Jan 7, 2021
Initiates: Neutral
Price Target: n/a
Current: $5.76
Upside: -
Nov 16, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $207.23
Upside: -
May 29, 2018
Maintains: Market Perform
Price Target: $170 → $160
Current: $881.94
Upside: -81.86%
Apr 4, 2018
Upgrades: Outperform
Price Target: n/a
Current: $74.02
Upside: -
Feb 9, 2018
Maintains: Outperform
Price Target: $90 → $85
Current: $72.80
Upside: +16.76%